Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-09-01
1991-11-19
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 33, 514 35, 536 41, 536 171, 536 181, 536 172, 536 184, A61K 3170, C07H 1520, C07H 1526
Patent
active
050666452
ABSTRACT:
The present invention provides antitumor 4'-Demethylepipodophyllotoxin glycosides characterized by the fact that the glycoside moiety is altrose.
REFERENCES:
patent: 3524844 (1970-08-01), Keller-Juslen et al.
patent: 4547567 (1985-10-01), Umezawa et al.
patent: 4564675 (1986-01-01), Kurabayashi et al.
patent: 4716221 (1987-12-01), Umezawa et al.
C. Keller-Juslen, et al., "J. Med. Chem.", 1971 (10) 936-940, Synthesis and Antimitotic Activity of Glycosidic Lignan Derivatives Related to Podophyllotoxin.sup.1.
H. Saito et al., "Chem. Lett.", 1987, 799-802, Syntheses of All Four Possible Diastereomers of Etoposide and Its Aminoglycosidic Analogues via Optical Resolution of (+)-Podophyllotoxin by Glycosidation with D- and L-Sugars.
K. Yamashita, et al., "J. Pharm. Biomed. Anal.", 1987, 5(1):11-20, Measurement of Plasma Etoposide by Radioimmunoassay.
Hoshi Hideaki
Kamei Hideo
Naito Takayuki
Ohnuma Takeshi
Bristol-Myers Company
Brown Johnnie R.
Carson Nancy S.
Yang Mollie M.
LandOfFree
Epipodophyllotoxin altroside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epipodophyllotoxin altroside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epipodophyllotoxin altroside derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1370447